Encompass Health (NYSE:EHC) Price Target Raised to $120.00 at KeyCorp

Encompass Health (NYSE:EHC) had its price objective raised by KeyCorp from $117.00 to $120.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

EHC has been the topic of a number of other research reports. Truist Financial restated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday, February 7th. Finally, Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Down 1.4 %

Shares of EHC stock opened at $98.04 on Monday. The stock’s 50-day simple moving average is $96.06 and its 200-day simple moving average is $95.43. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market capitalization of $9.88 billion, a PE ratio of 21.98, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a fifty-two week low of $72.53 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Equities analysts expect that Encompass Health will post 4.76 earnings per share for the current year.

Institutional Trading of Encompass Health

Institutional investors have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health in the third quarter worth approximately $40,000. Finally, CBIZ Investment Advisory Services LLC boosted its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.